bf/NASDAQ:CORT_icon.jpeg

COM:CORCEPT

Corcept Therapeutics

  • Stock

Last Close

46.89

31/10 20:00

Market Cap

5.12B

Beta: -

Volume Today

2.67M

Avg: -

Preview

Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page

Subscribe NowHelp
Dec '13
Dec '14
Dec '15
Dec '16
Dec '17
Dec '18
Dec '19
Dec '20
Dec '21
Dec '22
Dec '23
net income
-46.01M
-
-31.38M
31.79%
-6.41M
79.58%
8.14M
227.03%
129.12M
1,486.27%
75.41M
41.60%
94.18M
24.89%
106.01M
12.56%
112.51M
6.13%
101.42M
9.86%
106.14M
4.66%
depreciation and amortization
74K
-
141K
90.54%
155K
9.93%
87K
43.87%
106K
21.84%
236K
122.64%
2.17M
819.92%
2.24M
3.04%
3.07M
37.10%
2.97M
3.20%
2.36M
20.44%
deferred income tax
-76.70M
-
14.07M
118.34%
16.88M
19.98%
14.09M
16.52%
4.35M
69.15%
-33.91M
880.14%
-29.49M
13.01%
stock based compensation
5.20M
-
5.20M
0.10%
6.01M
15.61%
7.06M
17.38%
13.36M
89.30%
23.75M
77.73%
29.31M
23.44%
33.54M
14.42%
42.93M
28.00%
42.44M
1.14%
48.94M
15.31%
change in working capital
-762K
-
-5.04M
561.68%
500K
109.92%
1.16M
131.20%
-5.71M
594.29%
3.93M
168.71%
-4.69M
219.38%
-5.36M
14.29%
-57K
98.94%
6.02M
10,654.39%
8.22M
36.60%
accounts receivables
-871K
-
-1.91M
118.83%
-2.89M
51.47%
-3.64M
26.05%
-5.44M
49.49%
-2.29M
57.94%
-2.34M
2.27%
-6.27M
167.95%
-1.43M
77.24%
-3.43M
140.50%
-10.07M
193.30%
inventory
-883K
-
249K
128.20%
815K
227.31%
-682K
183.68%
-2.26M
231.67%
-7.78M
243.90%
-1.04M
86.58%
-3.51M
236.59%
3.44M
198.01%
1.20M
65.19%
1.26M
5.50%
accounts payables
-1.42M
-
-495K
65.21%
-561K
13.33%
965K
272.01%
6.29M
551.71%
-389K
106.19%
-735K
88.95%
3.16M
530.07%
-3.60M
213.79%
4.76M
232.25%
5.78M
21.46%
other working capital
2.42M
-
-2.89M
219.67%
3.13M
208.41%
4.51M
44.02%
-4.30M
195.32%
14.38M
434.39%
-568K
103.95%
1.27M
322.89%
1.52M
20.30%
3.49M
129.28%
11.24M
221.91%
other non cash items
4.45M
-
3.71M
16.60%
2.87M
22.58%
1.95M
32.06%
763K
60.87%
-1.72M
325.56%
-1.74M
0.99%
1.45M
183.49%
5.09M
251.00%
1.38M
72.85%
-9.13M
760.01%
net cash provided by operating activities
-37.06M
-
-27.38M
26.13%
3.13M
111.43%
18.39M
487.57%
60.94M
231.33%
115.67M
89.82%
136.12M
17.68%
151.97M
11.65%
167.89M
10.48%
120.32M
28.33%
127.04M
5.58%
investments in property plant and equipment
-127K
-
-174K
37.01%
-17K
90.23%
-194K
1,041.18%
-419K
115.98%
-298K
28.88%
-1.09M
265.10%
-1.24M
13.79%
-469K
62.12%
-413K
11.94%
-139K
66.34%
acquisitions net
116.74M
-
118.03M
1.10%
-136.59M
215.73%
113.91M
183.40%
-91.05M
179.92%
purchases of investments
-73.04M
-
-233.12M
219.19%
-299.04M
28.27%
-420.11M
40.49%
-312.81M
25.54%
-355.07M
13.51%
-328.75M
7.41%
sales maturities of investments
142.66M
-
182.29M
27.79%
302.09M
65.71%
449.40M
48.76%
241.15M
46.34%
419.79M
74.08%
other investing activites
-116.74M
-
-118.03M
1.10%
136.59M
215.73%
-113.91M
183.40%
91.05M
179.92%
net cash used for investing activites
-127K
-
-174K
37.01%
-17K
90.23%
-194K
1,041.18%
-73.46M
37,763.92%
-90.77M
23.57%
-117.83M
29.81%
-119.26M
1.22%
136.13M
214.14%
-114.33M
183.99%
90.91M
179.51%
debt repayment
-1.02M
-
-4.86M
373.76%
-9.21M
89.60%
-14.78M
60.52%
-15.13M
2.40%
-1.45M
-
-1.69M
16.05%
-2.02M
20.18%
-2.20M
8.59%
common stock issued
55K
-
8.42M
-
23.23M
175.88%
16.23M
30.13%
4.38M
73.01%
5.81M
32.64%
common stock repurchased
-23.66M
-
-30.98M
30.93%
-9.95M
67.89%
-295.99M
2,876.22%
-21.66M
92.68%
-145.43M
571.26%
dividends paid
-6.97M
-
-21.54M
209.19%
-14.20M
34.06%
-23.86M
68.01%
other financing activites
1.78M
-
22.28M
1,153.85%
7.68M
65.52%
7.18M
6.53%
9.32M
29.81%
2.33M
75.01%
22.16M
851.03%
-6.61M
129.81%
26.06M
494.54%
-9.11M
134.94%
net cash used provided by financing activities
-970K
-
-3.08M
217.42%
13.07M
524.62%
-7.10M
154.28%
-7.95M
12.08%
-14.34M
80.25%
-28.64M
99.83%
12.21M
142.64%
-302.59M
2,577.41%
-17.28M
94.29%
-148.72M
760.47%
effect of forex changes on cash
net change in cash
-38.16M
-
-30.63M
19.72%
16.19M
152.85%
11.10M
31.42%
-20.47M
284.43%
10.56M
151.59%
-10.36M
198.04%
44.92M
533.77%
1.43M
96.82%
-11.29M
891.03%
69.22M
713.24%
cash at beginning of period
93.03M
-
54.88M
41.01%
24.25M
55.81%
40.44M
66.76%
51.54M
27.45%
31.06M
39.73%
41.63M
34.01%
31.27M
24.88%
76.19M
143.66%
77.62M
1.87%
66.33M
14.54%
cash at end of period
54.88M
-
24.25M
55.81%
40.44M
66.76%
51.54M
27.45%
31.06M
39.73%
41.63M
34.01%
31.27M
24.88%
76.19M
143.66%
77.62M
1.87%
66.33M
14.54%
135.55M
104.36%
operating cash flow
-37.06M
-
-27.38M
26.13%
3.13M
111.43%
18.39M
487.57%
60.94M
231.33%
115.67M
89.82%
136.12M
17.68%
151.97M
11.65%
167.89M
10.48%
120.32M
28.33%
127.04M
5.58%
capital expenditure
-127K
-
-174K
37.01%
-17K
90.23%
-194K
1,041.18%
-419K
115.98%
-298K
28.88%
-1.09M
265.10%
-1.24M
13.79%
-469K
62.12%
-413K
11.94%
-139K
66.34%
free cash flow
-37.19M
-
-27.55M
25.91%
3.11M
111.30%
18.20M
484.55%
60.52M
232.56%
115.37M
90.64%
135.03M
17.04%
150.73M
11.63%
167.42M
11.07%
119.91M
28.38%
126.90M
5.83%

All numbers in (except ratios and percentages)